Sanders Morris Harris’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,500	Closed	-$659K	–	302
2025 Q1	$659K	Hold	21,500	–	–	0.1%	131
2024 Q4	$843K	Hold	21,500	–	–	0.13%	115
2024 Q3	$846K	Hold	21,500	–	–	0.14%	105
2024 Q2	$838K	Hold	21,500	–	–	0.14%	103
2024 Q1	$926K	Hold	21,500	–	–	0.17%	94
2023 Q4	$1.03M	Hold	21,500	–	–	0.51%	51
2023 Q3	$718K	Hold	21,500	–	–	0.15%	105
2023 Q2	$822K	Buy	+21,500	New	+$822K	0.18%	83
2023 Q1	–	Sell	-21,500	Closed	-$848K	–	248
2022 Q4	$848K	Hold	21,500	–	–	0.32%	66
2022 Q3	$778K	Sell	21,500 -3,000	-12%	-$109K	0.19%	85
2022 Q2	$754K	Buy	+24,500	New	+$754K	0.17%	94
2022 Q1	–	Sell	-24,500	Closed	-$771K	–	339
2021 Q4	$771K	Hold	24,500	–	–	0.13%	117
2021 Q3	$770K	Hold	24,500	–	–	0.14%	114
2021 Q2	$455K	Hold	24,500	–	–	0.09%	183
2021 Q1	$432K	Hold	24,500	–	–	0.09%	179
2020 Q4	$374K	Hold	24,500	–	–	0.09%	194
2020 Q3	$288K	Buy	+24,500	New	+$288K	0.08%	210